Total submissions: 5
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Gene |
RCV001718985 | SCV000723990 | likely benign | not provided | 2021-05-12 | criteria provided, single submitter | clinical testing | |
Ambry Genetics | RCV002377294 | SCV002625584 | likely benign | Cardiovascular phenotype | 2019-04-12 | criteria provided, single submitter | clinical testing | This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. |
Labcorp Genetics |
RCV002529747 | SCV003463015 | likely benign | Brugada syndrome | 2024-09-27 | criteria provided, single submitter | clinical testing | |
Ce |
RCV001718985 | SCV004698513 | likely benign | not provided | 2024-02-01 | criteria provided, single submitter | clinical testing | SCN10A: BP4, BP7 |
Women's Health and Genetics/Laboratory Corporation of America, |
RCV004586828 | SCV005076029 | benign | not specified | 2024-04-28 | criteria provided, single submitter | clinical testing |